HCAT R&D to Revenue
Health Catalyst Inc · R&D to Revenue
HCAT R&D to Revenue
Latest reported16.00%period ending
HCAT FY R&D/Revenue (38.96% → 16.00%)
Latest values, visible window
High-resolution chart · PNG
HCAT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 15.9962% | |
| 18.9018% | |
| 24.5413% | |
| 27.3969% | |
| 25.9307% | |
| 28.3391% | |
| 29.8514% | |
| 34.2815% | |
| 38.9568% |